-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
May 01, 2013 - ethnicity, socioeconomic status, and diverse specific
medical comorbidities (e.g., diabetes, end-stage renal … ethnicity, socioeconomic status, and diverse specific
medical comorbidities (e.g., diabetes, end-stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - literature is deficient in studies enrolling
people with varying levels of underlying
cardiovascular and renal
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - adults as well as in patients with advanced cancer and a
variety of other comorbidities, including renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mass-casualty-events-scarce-resources_executive.pdf
June 01, 2012 - available resources
Medical interventions (2 studies)
• Medical interventions for the prevention of acute renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
July 01, 2012 - of comparability of intact parathyroid
hormone measurements among commercial
assays for end-stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
June 06, 2011 - contrast agent used during the procedure to
visualize the coronary arteries may cause anaphylaxis or renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - percent being cleared by the kidneys,
and has a plasma half-life of 25 minutes in patients with
normal renal … consider subgroups by age,
sex, weight, body mass index, diabetes, heart failure,
previous stroke, renal … use of enoxaparin was associated with lower
rates of ischemic events in obese patients, those with
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - determine the long-term
consequences of “missed” or “delayed” diagnosis of SBI
such as decreased renal … Magnetic resonance
imaging detected renal volume reduction in refluxing and
nonrefluxing kidneys.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
November 01, 2012 - refers to the
cross-linking of polyethylene glycol molecules to the
interferon molecule, which delays renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - clinical “Acute Kidney Injury”, so
the implication is misleading, especially given
the long-term renal … “Renal-related Adverse Events” is a
more appropriate section header.
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - (e.g., those who have
experienced prior treatment failures, who have advanced cirrhosis, who have renal … genotype
4 infection and for treating patients with chronic HCV genotype 1 infection with end-stage
renal … 4 infection and another for
treating chronic HCV genotype 1 infection in patients with end-stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
January 01, 2014 - *End stage renal disease (ESRD) is a subset of CKD. In 2011, 6.2% of CKD beneficiaries had ESRD.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - 2 or 3 or 6 or 7 or 8
10 Medicare/
11 (medicare or disabled or disabilit* or kidney or renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - 2 or 3 or 6 or 7 or 8
10 Medicare/
11 (medicare or disabled or disabilit* or kidney or renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - were no clear differences between fluorescent
cystoscopy and white light cystoscopy in the risk of
renal … Fluorescent
vs. white light
cystoscopy:
renal and
genitourinary
adverse events
Low There were no … clear differences between
fluorescent cystoscopy and white light
cystoscopy in risk of renal and genitourinary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
October 27, 2009 - Crystalluria, glycosuria,
• Increased risk of nephrolithiasis
with long-term therapy
• Hematuria
• Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - conditions (Charlson Index, history of
chronic obstructive pulmonary disease, connective tissue disease, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
August 08, 2019 - efficacy of
nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - alter
the conclusions of a meta-analysis with
continuous outcomes: a case study of
changes in renal … monotherapy and
combination therapy with inhibitors of the
renin angiotensin system on proteinuria in
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - glucose levels in urine were
reported in some trials.
76
Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by
preventing renal